Our policy on research regulation
Medical research involving patients is one of the most heavily regulated sectors in the world.
Regulation ensures that patients are protected when taking part in research and that the data generated from research is robust and applicable to future clinical practice.
Our policy team works with researchers and regulators to ensure that the regulation that governs the research that is proportionate – protecting patients whilst ensuring unnecessary red tape does not impede our researchers.
In recent years the research community has highlighted numerous ways that European and UK laws along with processes in the NHS have damaged their ability to run clinical trials and research studies. This is because excessive or unnecessary regulation can slow down or stop clinical research taking place as well as greatly increase the cost to funders.
We’ve recently seen commitments from both the UK government and the EU to improve the situation for medical research. In the UK the formation of the Health Research Authority and a renewed focus on improving the approval times for research in the NHS are already having positive effects on our availability to conduct research. At an EU level the new Clinical Trials Regulation will make it easier and faster to set up a clinical trial.
We also work on other regulatory issues associated ranging from management of human tissue and ethical principles of research.
Statement: UK health and research community welcomes way forward for scientific advice in Europe
Letter to European Commission President on vital need to maintain Chief Scientific Adviser Post
Joint Statement on the Commission’s proposals for the Clinical Trials Regulation
Transforming the regulation and governance of health research in the UK
Supporting Research, protecting patient: Cancer Research UK’s recommendations to reform the Clinical Trials Directive
Response to House of Commons inquiry into leaving the EU: implications and opportunities for science and research
Comment on the UK Policy Framework for Health and Social Care Research
Response to the European Medicines Agency on the transparency addendum to the functional specifications for the EU portal and database
Cancer Research UK response to the Health Research Authority Strategy for Public Involvement
HRA’s Transparent Research Paper
Response to proposed updates to Declaration of Helsinki
Response to House of Commons Committee inquiry – Clinical Trials and Access to Data
Get in touch with our policy team to find out more information about our policy on supporting research.
Call our policy team for more information.